Search details
1.
Ternary Complex-Templated Dynamic Combinatorial Chemistry for the Selection and Identification of Homo-PROTACs.
Angew Chem Int Ed Engl
; 63(25): e202319456, 2024 Jun 17.
Article
in English
| MEDLINE | ID: mdl-38626385
2.
From combinations to multitarget-directed ligands: A continuum in Alzheimer's disease polypharmacology.
Med Res Rev
; 41(5): 2606-2633, 2021 09.
Article
in English
| MEDLINE | ID: mdl-32557696
3.
Fragment Merging, Growing, and Linking Identify New Trypanothione Reductase Inhibitors for Leishmaniasis.
J Med Chem
; 67(1): 402-419, 2024 Jan 11.
Article
in English
| MEDLINE | ID: mdl-38164929
4.
Targeted Protein Degradation for Infectious Diseases: from Basic Biology to Drug Discovery.
ACS Bio Med Chem Au
; 3(1): 32-45, 2023 Feb 15.
Article
in English
| MEDLINE | ID: mdl-37101607
5.
Innovative Approach for a Classic Target: Fragment Screening on Trypanothione Reductase Reveals New Opportunities for Drug Design.
Front Mol Biosci
; 9: 900882, 2022.
Article
in English
| MEDLINE | ID: mdl-35860359
6.
Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One.
J Med Chem
; 65(14): 9507-9530, 2022 07 28.
Article
in English
| MEDLINE | ID: mdl-35816671
7.
Riluzole-Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis.
ACS Chem Neurosci
; 13(15): 2252-2260, 2022 08 03.
Article
in English
| MEDLINE | ID: mdl-35868251
8.
Efficacy and safety of rituximab second-line therapy for membranous nephropathy: a prospective, matched-cohort study.
Am J Nephrol
; 33(5): 461-8, 2011.
Article
in English
| MEDLINE | ID: mdl-21508634
9.
Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer's Disease.
J Med Chem
; 64(8): 4972-4990, 2021 04 22.
Article
in English
| MEDLINE | ID: mdl-33829779
Results
1 -
9
de 9
1
Next >
>>